2014
DOI: 10.1016/j.jab.2013.04.001
|View full text |Cite
|
Sign up to set email alerts
|

Circadian haematotoxicity of the antiepileptic valproic acid in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 54 publications
0
1
0
Order By: Relevance
“…The drug act by suppressing repetitive neuronal firing through inhibition of voltage sensitive sodium channels. Valproate (VPA) has evidence as a neuroprotective at low doses [23,24,25] however at high doses most common toxicities include: hepatotoxicity [26]; haematotoxicity [27]; nephrotoxicity [28]; neurotoxicity [29], bone marrow suppression [26]; teratogenicity and developmental toxicity [30] and Valproate-induced hyperammonemic encephalopathy (VHE) [31].Valproate-induced hyperammonemic encephalopathy (VHE) is an unusual complication characterized by decreasing level of consciousness, focal neurological and cognitive deficits [32], and increased seizure frequency [33]. This is a form of toxicity peculiar to valproate which eventually leads to brain damage [9].Valproate treatment leads to deficiency in carnitine and also results in diminished mitochondrial function with inhibition of the urea cycle in the liver as metabolism of ammonia occurs primarily via the urea cycle.…”
Section: Introductionmentioning
confidence: 99%
“…The drug act by suppressing repetitive neuronal firing through inhibition of voltage sensitive sodium channels. Valproate (VPA) has evidence as a neuroprotective at low doses [23,24,25] however at high doses most common toxicities include: hepatotoxicity [26]; haematotoxicity [27]; nephrotoxicity [28]; neurotoxicity [29], bone marrow suppression [26]; teratogenicity and developmental toxicity [30] and Valproate-induced hyperammonemic encephalopathy (VHE) [31].Valproate-induced hyperammonemic encephalopathy (VHE) is an unusual complication characterized by decreasing level of consciousness, focal neurological and cognitive deficits [32], and increased seizure frequency [33]. This is a form of toxicity peculiar to valproate which eventually leads to brain damage [9].Valproate treatment leads to deficiency in carnitine and also results in diminished mitochondrial function with inhibition of the urea cycle in the liver as metabolism of ammonia occurs primarily via the urea cycle.…”
Section: Introductionmentioning
confidence: 99%